Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitor

Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitor

US Patent 9943596 · Granted Apr 17, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Artificial intelligence device for providing device control function based on in2025
Device and method for providing benchmark result of artificial intelligence base2024
Device and method for providing benchmark result of artificial intelligence base2024
Biomarker PNCK for predicting effect of a dual-targeting agent2020
Biomarker PNCK for predicting effect of a dual-targeting agent2020
Prediction of effect of a c-Met inhibitor using mutation of KRAS or BRAF2019
Polypeptide, anti-VEGF antibody, and anti-c-Met/anti-VEGF bispecific antibodies 2019
Combination therapy using P53 activator and c-Met inhibitor2019
Bispecific anti-Cmet/anti-Her2 antibodies2018
System and method for recognizing credit card number and expiration date using t2018
Divided hierarchical network system based on software-defined networks2018
Combination therapy using c-Met inhibitor and IGF-1R inhibitor for c-Met inhibit2018